Skip to main content

Transparency Review November 2022

Author - CMS | Published - 2022

“The lack of transparency in the functioning of the regulatory system is a major problem. Even basic information is not available, like names of medicines licensed for marketing and manufacture in India, brands of medicines in India and MRPs, names of manufacturers, list of vendors and manufacturers of bulk drugs and other ingredients going into a medicine. There is no way of knowing why certain drugs are approved again after being banned, and proceedings of committees which ban or approve them. The first step to solve the problem is to acknowledge that it exists and to bring complete transparency in the functioning of all healthcare regulatory agencies.”


Drug regulation needs a dose of transparency
Dinesh C Sharma
How India could end the malaise of 'missing' files that open the door to corruption
Shailesh Gandhi
Transparency and the Right to Information
"What it takes to sustain truly participatory movements and why we must fight for our democratic right to dissent"
Aruna Roy
Policy making though the third eye
M S Sriram

Transparency Review